GI Cancer

Clinical highlights, expert perspectives, and pivotal data from the ASCO gastrointestinal cancer sessions, showcasing emerging evidence and advancing therapeutic strategies.

GI Cancer

Dr. Neena Vijayvergia, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing key gastrointestinal trials at ASCO 2026 for clinical practice.

GI Cancer

07/02/2026

ASCO 2026: Key GI Trials Shaping Clinical Practice

Neena Vijayvergia, MDRahul Gosain, MD, MBARohit Gosain, MD

Two female medical professionals, Carolina Bernabe Ramirez and Cathy Eng, MD, FACP, FASCO, standing outdoors in front of a cityscape with a modern building, discussing pancreatic cancer research.

GI Cancer

06/25/2026

EPISODE-III and RASolute 302 Data From ASCO 2026

Carolina Bernabe Ramirez, MDCathy Eng, MD, FACP, FASCO

Dr. Brian Wolpin and colleagues discuss groundbreaking data for Daraxonrasib in mPDAC from the Phase 3 RASolute 302 Trial.

GI Cancer

06/18/2026

Phase 3 RASolute 302 Trial: Groundbreaking Data for Daraxonrasib in mPDAC

Brian Wolpin MD MPHRahul Gosain, MD, MBARohit Gosain, MD

Two medical professionals, a young woman and an older woman, standing in front of a cityscape with a river, discussing evolving hepatocellular carcinoma treatments.

GI Cancer

06/18/2026

Evolving HCC Treatment: Combining Immunotherapy and TACE

Antonella Cammarota, PhDLorenza Rimassa, MD

Aerial view of New York City skyline with river and park, highlighting advancements in pancreatic cancer treatment.

GI Cancer

06/15/2026

Daraxonrasib Delivers Game-Changing Survival Benefit in Previously Treated PDAC

Sunnie Kim, MD

GI Cancer

06/15/2026

RASolute 302: Evaluating the Side Effect Profile of Daraxonrasib

Shiraj Sen, MD, PhDRaji Shameem, MD

Two doctors discussing zanidatamab-based treatment options for HER2-positive gastric cancer against a city skyline background.

GI Cancer

06/10/2026

HERIZON-GEA-01 Updates and Sequencing HER2-Directed Treatments in Gastric Cancer

Geoffrey Ku, MDSteven Maron, MD, MSc

Two medical professionals, Joseph McCollom, DO, and Rachna Shroff, MD, MS, FASCO, discuss the latest updates on upper gastrointestinal cancer care at the Matterhorn conference.

GI Cancer

06/09/2026

GI Oncologists Discuss MATTERHORN Updates and Challenging HCC Subgroups

Joseph McCollom, DORachna Shroff, MD, MS, FASCO

Two medical professionals, Deepak Vadehra, DO and Charbel Matar, MD, discussing RASolution 302 and targeted therapy for gastrointestinal cancers in an urban setting.

GI Cancer

06/09/2026

Experts Review Groundbreaking Data From RASolute 302 and Its Impact on GI Oncology

Charbel Matar, MDDeepak Vadehra, DO

Zanidatamab emerging as a potential new standard of care in oncology, featuring Dr. Shruti Patel and Dr. Tanios Bekaii-Saab discussing innovative cancer treatment options.

GI Cancer

06/07/2026

Transformational Data From HERIZON-GEA-01 and RASolute 302 for GI Malignances

Tanios Bekaii-Saab, MDShruti Patel, MD

Aerial view of a city skyline with a waterfront, highlighting the latest insights from ASCO 2026 on evolving treatment strategies for gastrointestinal cancers.

GI Cancer

06/07/2026

Insights From ASCO 2026: Evolving Treatment Strategies in Gastrointestinal Malignancies

Aslihan Yerlikaya, MD

Modern metallic sculpture in an urban setting with skyscrapers, promoting the ASCO 2026 gastrointestinal cancer conference and research updates.

GI Cancer

05/15/2026

ASCO 2026: Gastrointestinal Abstracts to Watch

Raji Shameem, MD

Innovative cancer research expert speaking at OncUpdates conference, discussing latest advancements in oncology and personalized treatment strategies, in a professional setting.

GI Cancer

09/09/2025

Preferred Sequencing of Treatment for Neuroendocrine Tumors

Deepak Vadehra, DOTanios Bekaii-Saab, MD

Five major colorectal and gastrointestinal cancer abstracts from 2025 ASCO conference, analyzed by oncologists with insights on latest research and breakthroughs in cancer treatment.

GI Cancer

06/27/2025

Five Major Colorectal and GI Cancer Abstracts From 2025 ASCO

Rahul Gosain, MD, MBARohit Gosain, MDCathy Eng, MD, FACP, FASCO

Data for tomorrow’s oncology practice and research, oncological innovations, cancer treatment advancements, and cancer research updates at OncUpdates.

GI Cancer

06/11/2025

MATTERHORN Trial: Promising Results and Unanswered Questions

Deepak Vadehra, DOSupriya Peshin, MD

Innovative oncology research discussion at OncUpdates conference, focusing on advancements in cancer treatment, personalized medicine, and new therapies in oncology.

GI Cancer

06/11/2025

Diverse Bispecific Strategies Emerging Across GI Cancers

Shruti Patel, MDUdhayvir Singh Grewal, MD

Innovative cancer treatment discussion at Oncology conference focusing on advancements in oncology research, therapies, and patient care.

GI Cancer

06/10/2025

Interpreting the Broad Cabozantinib Label for NETs

Neena Vijayvergia, MDShruti Patel, MD

Expert woman in black blazer speaking at a medical conference, discussing oncology topics and cancer research on stage.

GI Cancer

06/10/2025

Considering Frontline PRRT in NETs

Neena Vijayvergia, MDShruti Patel, MD

Expert medical professionals discuss cancer treatment advances at an oncology conference, emphasizing personalized medicine and innovative research in cancer care.

GI Cancer

06/10/2025

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBSLisa Liu, MD

Enhanced visualization of the human digestive system highlighting the stomach and intestines for medical and anatomical research.

GI Cancer

06/03/2025

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO